| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 209.96B | 188.00B | 221.30B | 207.00B | 181.65B |
| Gross Profit | 99.96B | 131.32B | 142.81B | 150.81B | 133.79B |
| EBITDA | 108.73B | 49.99B | 72.99B | 89.82B | 76.59B |
| Net Income | 18.77B | -9.59B | 4.09B | 19.04B | 13.75B |
Balance Sheet | |||||
| Total Assets | 498.22B | 430.96B | 434.71B | 391.88B | 365.80B |
| Cash, Cash Equivalents and Short-Term Investments | 51.44B | 99.32B | 90.33B | 87.67B | 83.17B |
| Total Debt | 146.58B | 155.74B | 148.45B | 137.84B | 128.82B |
| Total Liabilities | 328.66B | 292.51B | 284.53B | 269.54B | 250.82B |
| Stockholders Equity | 144.85B | 123.44B | 139.21B | 116.60B | 111.05B |
Cash Flow | |||||
| Free Cash Flow | 41.74B | 15.14B | 17.26B | 22.31B | 32.06B |
| Operating Cash Flow | 72.19B | 46.82B | 64.06B | 68.12B | 67.29B |
| Investing Cash Flow | -38.94B | -33.34B | -52.26B | -43.44B | -30.95B |
| Financing Cash Flow | -21.97B | -16.20B | -9.48B | -17.42B | -26.18B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $18.05B | 16.17 | 15.56% | 6.14% | -5.21% | -7.45% | |
70 Outperform | $26.63B | 17.32 | 9.03% | 5.03% | -3.16% | 4.70% | |
62 Neutral | $21.22B | 16.48 | 10.60% | 1.26% | 6.96% | ― | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
60 Neutral | $36.36B | 7.35 | -8.37% | 3.77% | 19.67% | -278.51% | |
57 Neutral | $12.70B | 27.39 | 3.37% | 5.02% | -8.16% | -52.52% |